Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06567197
What this trial is testing

Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Amsterdam UMC, location VUmc 24
Not applicableLooking for participantsNCT06218927
What this trial is testing

The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients

Who this might be right for
Multiple SclerosisLower Urinary Tract Symptoms
University Hospital Ostrava 40
Testing effectiveness (Phase 2)Study completedNCT02035514
What this trial is testing

Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Germans Trias i Pujol Hospital 9
Large-scale testing (Phase 3)Ended earlyNCT03342638
What this trial is testing

Maximizing Outcome of Multiple Sclerosis Transplantation

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Northwestern University 66
Not applicableNo Longer AvailableNCT02084121
What this trial is testing

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

Who this might be right for
Metachromatic Leukodystrophy
Talaris Therapeutics Inc.
Not applicableUnknownNCT06195800
What this trial is testing

Biomarkers of aHSCT

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Sheffield Teaching Hospitals NHS Foundation Trust 15
Not applicableStudy completedNCT04844489
What this trial is testing

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Who this might be right for
Autoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more
Assistance Publique - Hôpitaux de Paris 377
Not applicableUnknownNCT02529839
What this trial is testing

Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Hadassah Medical Organization 20
Not applicableStudy completedNCT05544448
What this trial is testing

In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases

Who this might be right for
Autoimmune DiseasesInflammatory DiseaseAcquired Bone Marrow Aplasia+8 more
Assistance Publique - Hôpitaux de Paris 67
Early research (Phase 1)Looking for participantsNCT05832515
What this trial is testing

AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
St. Petersburg State Pavlov Medical University 200
Testing effectiveness (Phase 2)Study completedNCT00342134
What this trial is testing

Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 34
Testing effectiveness (Phase 2)Study completedNCT01377870
What this trial is testing

Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Royan Institute 22
Testing effectiveness (Phase 2)Ended earlyNCT01228266
What this trial is testing

Mesenchymal Stem Cell Transplantation in MS

Who this might be right for
Multiple Sclerosis
Albert Saiz 9
Large-scale testing (Phase 3)Looking for participantsNCT04047628
What this trial is testing

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

Who this might be right for
Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 156
Large-scale testing (Phase 3)Active Not RecruitingNCT03477500
What this trial is testing

Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)

Who this might be right for
Multiple Sclerosis
Haukeland University Hospital 100
Early research (Phase 1)Ended earlyNCT04203017
What this trial is testing

Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
St. Petersburg State Pavlov Medical University 20
Not applicableLooking for participantsNCT04014413
What this trial is testing

Safety and Efficacy of Fecal Microbiota Transplantation

Who this might be right for
Crohn DiseaseUlcerative ColitisCeliac Disease+24 more
Chinese University of Hong Kong 450
Testing effectiveness (Phase 2)WithdrawnNCT00497952
What this trial is testing

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT01099930
What this trial is testing

Autologous Stem Cell Transplant for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Ottawa Hospital Research Institute 24
Next Page